Sekisui Diagnostics Receives FDA Clearance for SEKURE® HbA1c Assay
LEXINGTON, Massachusetts, July 30, 2018 /PRNewswire/ — Sekisui Diagnostics announces the FDA clearance of their SEKURE® HbA1c assay. The assay has been cleared to be used as an aid in the diagnosis of diabetes mellitus,